These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 7022208

  • 1. Oral contraceptives and cardiovascular disease (first of two parts).
    Stadel BV.
    N Engl J Med; 1981 Sep 10; 305(11):612-8. PubMed ID: 7022208
    [No Abstract] [Full Text] [Related]

  • 2. [Oral contraceptives: update].
    Fugère P.
    Union Med Can; 1983 Feb 10; 112(2):109-12. PubMed ID: 6845551
    [No Abstract] [Full Text] [Related]

  • 3. Oral contraceptives and the risk of cardiovascular disease.
    Med Lett Drugs Ther; 1983 Jul 22; 25(640):69-70. PubMed ID: 6865850
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1998 Jul 22; 877():i-vii, 1-89. PubMed ID: 9615606
    [Abstract] [Full Text] [Related]

  • 5. Oral contraceptives and cardiovascular disease (second of two parts).
    Stadel BV.
    N Engl J Med; 1981 Sep 17; 305(12):672-7. PubMed ID: 7022211
    [No Abstract] [Full Text] [Related]

  • 6. Thromboembolism and oral contraceptives.
    Br Med J; 1974 Feb 09; 1(5901):213. PubMed ID: 4818158
    [No Abstract] [Full Text] [Related]

  • 7. [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].
    Herzog C.
    Schweiz Rundsch Med Prax; 1979 Oct 09; 68(41):1321-9. PubMed ID: 394143
    [No Abstract] [Full Text] [Related]

  • 8. Hormonal replacement therapy--cardiovascular disease.
    Silfverstolpe G, Crona N.
    Acta Obstet Gynecol Scand Suppl; 1986 Oct 09; 134():93-5. PubMed ID: 3028030
    [No Abstract] [Full Text] [Related]

  • 9. Oral contraceptives and endometrial and cervical cancer.
    Moghissi KS.
    J Toxicol Environ Health; 1977 Sep 09; 3(1-2):243-65. PubMed ID: 336901
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical and metabolic effects of oral contraceptives].
    Vázquez Hernández L, Téllez Martínez J, Hicks Gómez JJ.
    Ginecol Obstet Mex; 2000 Feb 09; 68():64-9. PubMed ID: 10774107
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May 09; 57(5):315-24. PubMed ID: 9673838
    [Abstract] [Full Text] [Related]

  • 12. [Current aspects of the oral hormonal contraception].
    Avramova V.
    Akush Ginekol (Sofiia); 2008 May 09; 47 Suppl 2():49-59. PubMed ID: 19504710
    [No Abstract] [Full Text] [Related]

  • 13. [The pill and thromboembolism. 2. Pathogenesis and additional risk factors. Review of the literature].
    Herzog C, Mall-Haefeli M.
    Ther Ggw; 1979 Nov 09; 118(11):1722-44. PubMed ID: 395715
    [No Abstract] [Full Text] [Related]

  • 14. [Oral contraceptives: pharmacotherapy of normal women (author's transl)].
    Bühler FR.
    Schweiz Rundsch Med Prax; 1976 Jan 06; 65(1):3-5. PubMed ID: 1250821
    [Abstract] [Full Text] [Related]

  • 15. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
    Beller F, Theiss W.
    Zentralbl Gynakol; 1994 Jan 06; 116(8):441-8. PubMed ID: 7941812
    [Abstract] [Full Text] [Related]

  • 16. [Hormonal contraceptive therapy and thromboembolic disease].
    Narvaiza MJ, Hernández M, Arrizabalaga B, Solana JM, Pérez Val JA, Rocha E.
    Rev Med Univ Navarra; 1980 Dec 06; 24(4):49-53. PubMed ID: 7038816
    [Abstract] [Full Text] [Related]

  • 17. Two minutes with the oral contraceptives.
    Warren MP.
    Med Times; 1973 Mar 06; 101(3):129-30 passim. PubMed ID: 4687935
    [No Abstract] [Full Text] [Related]

  • 18. Changing oral contraceptives.
    Br Med J; 1969 Dec 27; 4(5686):789-91. PubMed ID: 5359946
    [No Abstract] [Full Text] [Related]

  • 19. Low-dose oral contraceptives: progestin potency, androgenicity, and atherogenic potential.
    Ellis J.
    Clin Ther; 1986 Dec 27; 8(6):607-18. PubMed ID: 3539347
    [Abstract] [Full Text] [Related]

  • 20. [Hormonal contraceptives, peripheral venous insufficiency and the use of a phlebodynamic agent].
    Cervantes A, Gorodovsky J, Peña A, Campos J.
    Ginecol Obstet Mex; 1976 Aug 27; 40(238):113-6. PubMed ID: 786800
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.